|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2000-9-11
|
|
pubmed:abstractText |
Most patients with peritoneal carcinomatosis of digestive tract origin die within 6 months. Intraperitoneal chemohyperthermia (IPCH) associated with surgery has been reported as a possible new therapeutic approach.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2512-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10861427-Adult,
pubmed-meshheading:10861427-Aged,
pubmed-meshheading:10861427-Antibiotics, Antineoplastic,
pubmed-meshheading:10861427-Carcinoma,
pubmed-meshheading:10861427-Combined Modality Therapy,
pubmed-meshheading:10861427-Equipment Design,
pubmed-meshheading:10861427-Female,
pubmed-meshheading:10861427-Gastrointestinal Neoplasms,
pubmed-meshheading:10861427-Humans,
pubmed-meshheading:10861427-Hyperthermia, Induced,
pubmed-meshheading:10861427-Infusions, Parenteral,
pubmed-meshheading:10861427-Male,
pubmed-meshheading:10861427-Middle Aged,
pubmed-meshheading:10861427-Mitomycin,
pubmed-meshheading:10861427-Peritoneal Neoplasms,
pubmed-meshheading:10861427-Prospective Studies,
pubmed-meshheading:10861427-Survival Rate
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis.
|
|
pubmed:affiliation |
Oncologic Hyperthermia Laboratory, Université C.B. Lyon-I, Oullins, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
